Investors largely expected the FOMC to cut rates by a quarter point.The Fedread more
The lack of clarity surrounding the U.S.-China trade war is what's really hitting global growth, says ex- Deputy Treasury Secretary Sarah Bloom Raskin.World Economyread more
China's economy has long relied on factors such high levels of investments and an expanding labor force for growth. Those growth drivers are running out of steam.China Economyread more
India could benefit from the fallout in the U.S.-China trade war, experts told CNBC — but much-needed reforms on land and labor could prove to be a challenge for companies...Asia Economyread more
New crash tests show the Tesla Model 3 and the Audi e-tron, are among the safest models out on the road. The results bolster the theory electric vehicles may be better...Autosread more
U.S. consumers and growth in sectors such as technology have offset declines in other American industries, says Tom Finke, chairman and CEO of investment management firm...US Economyread more
The FAA administrator's comments come on the eve of his visit to Boeing facilities outside Seattle. While there, he's scheduled to meet with Boeing executives and be briefed...Airlinesread more
Last weekend's attacks on oil facilities — and the spike in crude prices that followed — should show that the world needs to stop relying on oil, says Helen Clark.Energyread more
The photo depicts Canadian leader Justin Trudeau wearing a turban and robe, with dark makeup on his hands, face and neck. Liberal Party spokesman confirms the photo is of...Electionsread more
As the Fed was meeting to consider cutting interest rates, it lost control of the very benchmark rate that it manages.Market Insiderread more
CBS, CNN and other major media companies are starting to pull e-cigarette advertising off their airways, as the death toll from a mysterious vaping-related illness continues...Health and Scienceread more
The Wall Street Journal reported Monday that Walgreens is in talks to acquire the portion of major drug distributor AmerisourceBergen it doesn't already own. The pharmacy chain first bought a stake in AmerisourceBergen in 2013 and has grown it to 26 percent in the nearly five years since.
Walgreens and AmerisourceBergen declined to respond to CNBC's requests for comment.
The deal would follow Walgreens' strategy of partnering with a company to evaluate it before outright buying it, though they don't always. Therefore the report wasn't entirely shocking, but it was surprising to some, given rival pharmacy chain CVS Health is taking a different approach with its planned acquisition of health insurer Aetna.
Both deals, in theory, could lower costs and drive traffic to retail stores, but they would do so in different ways.
The plans come as Amazon's entry into the health-care space stokes anxiety about the logistical mastermind disrupting the industry the same way it has numerous others. Amazon is partnering with J.P. Morgan and Berkshire Hathaway to create a not-for-profit health-care company aimed at using technology to lower costs. That move, combined with chatter about other steps Amazon may take, have rocked health-related stocks.
"I wouldn't say this is in response to CVS-Aetna or Amazon," said Leerink analyst David Larsen. "It may have been accelerated given the CVS-Aetna deal, but I would say it's sort of their normal operating playbook. It's interesting how Walgreens is moving downstream to distribution where CVS is moving upstream to a managed care plan. It's just different strategies."
The idea behind CVS' planned $69 billion acquisition of Aetna is the two can lower health costs by creating an integrated health system that combines pharmacy and health benefits with retail clinics. Walgreens buying AmerisourceBergen could lower costs in a different way.
Distributors buy drugs from manufacturers and handle the logistics of getting them to providers and pharmacies. They negotiate prices with pharmaceutical companies, making them an important piece of the supply chain. Buying AmerisourceBergen would put that piece of the chain under Walgreens' control.
The deal would add financial value for Walgreens over time, analysts said. Walgreens is valued at $67.82 billion, and AmerisourceBergen has a market capitalization of $19.65 billion, according to Thomson Reuters data.
However, some questioned the rationale for a possible deal. Jefferies analyst Brian Tanquilut called it "a little bit of a headscratcher" in a research note.
"(Walgreens Boots Alliance) has been openly discussing their intention of continuing to pursue vertical-integration deal opportunities, but acquiring the rest of (AmerisourceBergen), while financially rational, begs the question on what incremental strategic value the deal would bring, especially in light of recent moves by CVS and (Aetna) and even (Express Scripts) buying eviCore," Tanquilut wrote.
It's critical to remember these deals, though newsworthy, will not be CVS' nor Walgreens' last, said Cowen analyst Charles Rhyee. Despite the hype, he doesn't think Amazon has all the answers, noting other tech companies have tried and failed to change health care.
"It's almost like thinking on what Amazon will do you're assuming people in (the health-care industry) have no idea what they're doing and are still sitting on their hands," Rhyee said. "I don't think that's necessarily the case. If it was such a simple problem, it would have been solved a long time ago. There's room for a lot of potential ideas to solve it."